1. Home
  2. QNCX vs LODE Comparison

QNCX vs LODE Comparison

Compare QNCX & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • LODE
  • Stock Information
  • Founded
  • QNCX 2012
  • LODE 2008
  • Country
  • QNCX United States
  • LODE United States
  • Employees
  • QNCX N/A
  • LODE N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • LODE Major Chemicals
  • Sector
  • QNCX Health Care
  • LODE Industrials
  • Exchange
  • QNCX Nasdaq
  • LODE Nasdaq
  • Market Cap
  • QNCX 62.0M
  • LODE 79.6M
  • IPO Year
  • QNCX 2019
  • LODE N/A
  • Fundamental
  • Price
  • QNCX $1.40
  • LODE $0.37
  • Analyst Decision
  • QNCX Strong Buy
  • LODE Buy
  • Analyst Count
  • QNCX 4
  • LODE 1
  • Target Price
  • QNCX $9.50
  • LODE $2.60
  • AVG Volume (30 Days)
  • QNCX 126.2K
  • LODE 9.3M
  • Earning Date
  • QNCX 03-31-2025
  • LODE 02-26-2025
  • Dividend Yield
  • QNCX N/A
  • LODE N/A
  • EPS Growth
  • QNCX N/A
  • LODE N/A
  • EPS
  • QNCX N/A
  • LODE N/A
  • Revenue
  • QNCX N/A
  • LODE $1,864,811.00
  • Revenue This Year
  • QNCX N/A
  • LODE $69.41
  • Revenue Next Year
  • QNCX N/A
  • LODE $56.83
  • P/E Ratio
  • QNCX N/A
  • LODE N/A
  • Revenue Growth
  • QNCX N/A
  • LODE 117.46
  • 52 Week Low
  • QNCX $0.51
  • LODE $0.13
  • 52 Week High
  • QNCX $2.45
  • LODE $1.01
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 36.64
  • LODE 44.98
  • Support Level
  • QNCX $1.37
  • LODE $0.35
  • Resistance Level
  • QNCX $1.69
  • LODE $0.41
  • Average True Range (ATR)
  • QNCX 0.12
  • LODE 0.03
  • MACD
  • QNCX -0.02
  • LODE 0.00
  • Stochastic Oscillator
  • QNCX 9.71
  • LODE 33.33

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.

About LODE Comstock Inc.

Comstock Inc is engaged in technologies that efficiently use wasted and under-utilized natural resources to produce renewable energy and other products that contribute to balancing uses and emissions of carbon and enhance mineral and material discoveries. The segments of the company are Fuels Metals, Mining, Strategic Investments, and Corporate. The company derives maximum revenue from Strategic Investments segment. The Strategic Investments Segment includes minority equity investments in Quantum Generative Materials LLC (physics-based artificial intelligence), Green Li-ion Pte Limited (lithium-ion battery recycling and cathode production), Sierra Springs Opportunity Fund (strategic direct investment in northern Nevada real estate), and other equity or equity-linked investments.

Share on Social Networks: